Lensar (LNSR) Shares Outstanding (Diluted Average) (2021 - 2026)
Lensar (LNSR) reported Shares Outstanding (Diluted Average) of $15.4 million for Q1 2026, up 30.97% year-over-year from $11.8 million in Q1 2025, and up 28.95% on a QoQ basis from $12.0 million in Q4 2025.
Lensar (LNSR) has 6 years of Shares Outstanding (Diluted Average) data on file, last reported at $15.4 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 30.97% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.4 million (up 30.97% YoY) and the FY2025 annual result came in at $12.0 million, up 3.82% from the prior year.
- Shares Outstanding (Diluted Average) grew to $15.4 million in Q1 2026 per LNSR's latest filing, from $12.0 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $15.4 million in Q1 2026 and bottomed at $10.0 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $11.4 million (2024), against an average of $11.4 million.
- The widest annual swing landed in 2025, when Shares Outstanding (Diluted Average) climbed 2.72%; it then surged 30.97% in 2026.
- Tracing LNSR's Shares Outstanding (Diluted Average) over 5 years: stood at $10.2 million in 2022, then grew by 7.99% to $11.0 million in 2023, then advanced by 4.99% to $11.5 million in 2024, then climbed by 3.82% to $12.0 million in 2025, then climbed by 28.95% to $15.4 million in 2026.
- Per Business Quant, the three latest LNSR Shares Outstanding (Diluted Average) figures stand at $15.4 million (Q1 2026), $12.0 million (Q4 2025), and $11.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 15.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.42 Mn |
| Dec 31, 2025 | 11.96 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Jun 30, 2025 | 11.86 Mn |
| Mar 31, 2025 | 11.77 Mn |
| Dec 31, 2024 | 11.52 Mn |
| Sep 30, 2024 | 11.60 Mn |
| Jun 30, 2024 | 11.42 Mn |
| Mar 31, 2024 | 11.39 Mn |
| Dec 31, 2023 | 10.97 Mn |
| Jun 30, 2023 | 10.82 Mn |
| Mar 31, 2023 | 10.72 Mn |
| Dec 31, 2022 | 10.16 Mn |
| Sep 30, 2022 | 10.23 Mn |
| Jun 30, 2022 | 10.02 Mn |
| Mar 31, 2022 | 9.97 Mn |
| Dec 31, 2021 | 9.37 Mn |
| Sep 30, 2021 | 9.44 Mn |
| Jun 30, 2021 | 9.24 Mn |